News And Events

Screenshot 2025-05-07 154446
Screenshot 2025-05-07 161752
Screenshot 2025-05-07 163014
Screenshot 2025-05-07 162413

🚀 We are excited to announce that the second webinar dedicated to the IMPACT Project was successfully held yesterday! The webinar, in collaboration with the REMODEL project, featured contributions from leading experts engaged in cutting-edge biomedical research. 🌟During the webinar, Yvan Torrente, professor at the Ospedale Policlinico di Milano and coordinator of REMODEL, and Chiara...

🔔 REMINDER: Don’t miss our second webinar!

🔔 Don’t miss our next webinar “REMODEL & IMPACT: Omics for Tomorrow’s Medicine“! We are just a few days away from the webinar of the IMPACT and REMODEL projects, dedicated to omics techniques and their applications in biomedical research. Join us to discover how integrative omics approaches are changing our knowledge of neuromuscular diseases and...

Second webinar | REMODEL & IMPACT: Omics for Tomorrow’s Medicine

IMPACT and REMODEL projects are excited to invite you to participate in a webinar that aims to explore the omics techniques and how these are used in biomedical research. The webinar will provide an opportunity to discuss innovative omics data integration approaches that are revolutionising biomedical research and personalised therapies for neuromuscular diseases and arrhythmogenic...

First Webinar | Advancing cardiomyopathy research through AI: the role of IMPACT Project

The IMPACT Project is excited to invite you to a dedicated webinar, an opportunity to explore innovative approaches in the treatment of arrhythmogenic cardiomyopathy (ACM). During the webinar, we will explore the IMPACT Project and its partners, focusing on the importance of cardiomyopathies and the role of artificial intelligence (AI) in the discovery of new therapies, through the voices of...

IMPACT project officially starts – 01/10/2023

The IMPACT project has officially started! With 7 Partners from different EU countries 🇪🇺 ,  IMPACT will implement an Artificial Intelligence (AI)-based integration of clinical and -omics data from ACM patient registry utilizing unsupervised mixed-data clustering and phenomapping to identify phenotypic subgroups within the cohort of patients leading to the detection of therapeutically actionable targets...